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Brown-Pigmented Mycobacterium mageritense as a Cause of Prosthetic
Valve Endocarditis and Bloodstream Infection
Allison R. McMullen,a Caline Mattar,b Nigar Kirmani,b Carey-Ann D. Burnhama
Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine,a and Department of Medicine, Division of Infectious Diseases,b Washington
University School of Medicine, St. Louis, Missouri, USA
Mycobacterium spp. are a rare cause of endocarditis. Herein, we describe a case ofMycobacteriummageritense prosthetic valve
endocarditis. This organism produced an unusual brown pigment on solid media. Cultures of valve tissue for acid-fast bacilli
might be considered in some cases of apparently culture-negative prosthetic valve endocarditis.
CASE REPORT
A 47-year-old woman with a past medical history of a rheu-matic aortic stenosis, status post-mechanical aortic valve re-
placement 6 months prior to the onset of symptoms, presented for
medical care with a chief complaint of severe headache and left-
sided weakness. A computed tomography (CT) scan demon-
strated a subarachnoid hemorrhage in the right parietal lobe.
Magnetic resonance imaging (MRI) and angiogram did not reveal
any vascular etiology for the stroke. Two sets of blood cultures
were drawn upon admission (each set included two bottles):
VersaTREK REDOX1 (aerobic) and REDOX2 (anaerobic) (TREK
Diagnostic Systems, Cleveland, OH) and were negative after 5
days of incubation. The patient was restarted on anticoagulants
and discharged.
Approximately 1 month later, she presented to an outside hos-
pital with complaints of a severe, persistent headache. At this time,
a CT scan illustrated multiple punctate 6- to 7-mm foci of intra-
parenchymal hemorrhage within the right frontal lobe. She was
transferred to our institution for further workup and manage-
ment. During this visit, a transesophageal echocardiogram dem-
onstrated two mechanical aortic valve vegetations, an aortic root
abscess, and a possible early valve dehiscence. One blood culture
set was collected on day 2 posttransfer, and two sets were collected
on days 3 and 4 posttransfer. The patient was started on an em-
pirical regimen of cefepime, rifampin, vancomycin, and gentami-
cin for early prosthetic valve endocarditis.
After approximately 100 h of incubation, one bottle from each
of two blood culture sets (the REDOX1 bottles) was positive with
acid-fast bacilli (AFB). Four additional blood culture sets (all
REDOX1 bottles) became positive over the next few days, all con-
taining AFB and all incubating for approximately 100 h prior to
signaling positive. There was no growth in any of the REDOX2
(anaerobic) bottles. Positive blood cultures were subcultured to
Middlebrook 7H10 agar plates (Remel, Lenexa, KS) and Lowen-
stein-Jensen (LJ) agar slants (Becton Dickinson, Sparks, MD) and
incubated at 35°C. Buff-colored colonies were present on both
plates within 3 days of inoculation. A Kinyoun stain was per-
formed to confirm that the isolate was an acid-fast bacillus (Fig. 1).
Seven to 10 days after subculture onto the 7H10 agar, it was noted
that the colonies appeared to have a dark brown pigment (Fig. 2).
Cultures were sent to the Wisconsin State Laboratory of Hygiene
for identification and susceptibility testing. The organism was
identified as Mycobacterium mageritense by rpoB gene sequencing
and was susceptible to amikacin, cefoxitin, ciprofloxacin, doxycy-
cline, imipenem, linezolid, trimethroprim-sulfamethoxazole, and
moxifloxacin and resistant to clarithromycin (MIC of 16 g/ml
after 4 days of incubation) and tobramycin. Upon identification of
AFB in the blood cultures, the patient was started on amikacin,
moxifloxacin, azithromycin, and imipenem. After the organism
was identified and susceptibility testing was available, the antibi-
otic regimen was modified to doxycycline, moxifloxacin, and imi-
penem. Subsequent blood cultures were negative.
Approximately 6 weeks after admission, the patient underwent
a valve replacement surgery without complication and was dis-
charged 10 days later on doxycycline, moxifloxacin, and imi-
penem. Cultures of the valve, fluid, and aortic root were submitted
for aerobic and anaerobic cultures and were negative for growth;
no organisms were seen on the Gram stain of the specimen. The
valve tissue was also submitted for AFB culture and was positive
for the growth of AFB 4 weeks later. Again, the organism produced
a brown pigment on 7H10 agar. The valve culture was sent to the
Wisconsin State Laboratory of Hygiene for identification and was
identified as M. mageritense by rpoB gene sequencing.
Mycobacterium mageritense was first characterized in 1997 (1).
Five nonpigmented, rapidly growing strains were isolated from
human sputum from patients from two different medical centers
between 1987 and 1989 in Spain. Biochemical analyses and partial
gene sequencing demonstrated that M. mageritense had similari-
ties to both Mycobacterium smegmatis and Mycobacterium fortui-
tum. Additional studies on six strains from the United States
(three isolates from Texas, one from New York, one from Louisi-
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ana, and one from Florida) were performed in 2002 (2). These
isolates were recovered from sputum, bronchial wash, blood, si-
nus drainage, and surgical wound infections. Like the Spanish
isolates, it was reported that the U.S. isolates produced nonpig-
mented colonies on both Trypticase soy agar and 7H10 agar at
both 30 and 35°C, with variable growth at 45°C. All isolates were
determined to be susceptible to ciprofloxacin and resistant to cla-
rithromycin. Five of the six U.S. isolates also tested as resistant to
tobramycin, while all of the Spanish isolates were susceptible. The
disease presentation, antimicrobial susceptibility, and biochemi-
cal profile of the U.S. isolates were determined to be similar to
those of the M. fortuitum third biovariant complex. Studies in-
cluding partial gene sequencing and high-performance liquid
chromatography (HPLC) and restriction fragment length poly-
morphism (RFLP) analyses have demonstrated that the M. fortui-
tum third biovariant complex includes Mycobacterium septicum,
Mycobacterium houstonense, Mycobacterium bonickei, and M. ma-
geritense (2, 3). More recent phylogenetic analyses interrogating
multiple genes, including 16S rRNA gene sequencing, classify M.
mageritense as closely related to Mycobacterium wolinskyi, Myco-
bacterium goodii, and Mycobacterium smegmatis (4). The M. mag-
eritense isolate in our case had growth of smooth, buff-colored
colonies within 3 days following subculture at both 30 and 35°C.
At 42°C, the culture had a rough, dry colony morphology that was
buff colored. The isolate also grew well on both blood and choc-
olate agars. One week after subculturing, the isolate incubated at
35°C produced a brown pigment that became darker over time
(Fig. 2). Four days later, the culture incubated at 30°C began to
produce a faint brown pigment that became dark brown by 14
days post-subculture. Matrix-assisted laser desorption ioniza-
tion–time of flight mass spectrometry (MALDI-TOF MS) analy-
ses was performed to further characterize the isolate using previ-FIG 2 Patient isolate at 35°C 7 days post-subculture.
FIG 1 Kinyoun stain of patient isolate cultured on 7H10 agar at 35°C. Magnification,1,000.
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ously described methods (5). The isolate was identified as M.
mageritense with the Vitek MS platform and Saramis database. No
identification was obtained using the Bruker Biotyper using the
mycobacteria library version 1.0 (although this species is in the
Biotyper database).
Mycobacterium spp. are an unusual cause of endocarditis, with
the majority of cases attributed to rapid growing mycobacteria.
There have been 13 published case reports between 1975 and 2012
of M. fortuitum-associated endocarditis in four patients with na-
tive valves and nine patients with prosthetic valves (6, 7). The
range of clinical onset was between 1 and 12 months. Most of the
cases also had positive blood cultures, and two out of four patients
who underwent echocardiography showed the presence of vege-
tations. Other rapidly growing mycobacteria causing endocarditis
include Mycobacterium chelonae and Mycobacterium abscessus and
have been reported in 10 patients with prosthetic valves (7–9).
Thirteen cases of endocarditis in Serbia were traced to prosthetic
valves that were contaminated with M. chelonae during the man-
ufacturing process (10). There have been two published cases of
Mycobacterium neoaurum endocarditis, both in intravenous drug
users, and one reported case of prosthetic valve endocarditis
caused by M. goodii (11–13).
The prognosis of patients with endocarditis from rapid grow-
ing mycobacteria is poor, with mortality rates of 85 to 100% in
patients with prosthetic valves (7, 8). Selection of antimicrobials
for treatment varies, depending on organism identification, and
susceptibility testing and surgical removal of the valve are fre-
quently recommended (8).
To our knowledge, our case provides only the second pub-
lished report in the literature describing a brown-pigmented my-
cobacterium. In 1976, Hawkins and Falco (14) published a study
examining one mycobacterial isolate from sputum that produced
rough colonies with a dark brown pigment on LJ and 7H10 agar.
Like our isolate, the colony began growing within 3 to 7 days, with
brown pigment being produced 7 to 13 days after subculture. Un-
like our isolate, the isolate described in this original paper had a
rough texture. The isolate was identified to be most closely related
toM. fortuitum by three independent laboratories using biochem-
ical analyses. Comparison of biochemical data for the brown-pig-
mented M. fortuitum and M. mageritense isolates described by
Domenech et al. (1) demonstrate that the brown-pigmented iso-
late is very similar to M. mageritense, except for Tween hydrolysis
and catalase production at 68°C. To further characterize our iso-
late, we incubated it at three different temperatures (30, 35, and
42°C) for 14 days (Fig. 3). Buff-colored growth was present at all
three temperatures after 3 days of incubation, with smooth colo-
nies present at 30 and 35°C and rough colonies at 42°C. Dark
brown pigmentation was present after 7 days at 30°C, and a very
light brown pigmentation was visible at 35°C. Again, the colonies
were smooth. At 7 days, there was no visible brown pigment at
42°C. By 14 days, the culture incubated at 35°C had a brown pig-
ment similar to the culture incubated at 30°C.
In summary, to our knowledge, our patient is the first case of
M. mageritense-associated endocarditis. Additionally, we report
the second case in the literature of brown-pigmented mycobacte-
ria. As M.mageritense is a newly described species, we hypothesize
that the prior case may have also been M. mageritense, although
this cannot be confirmed in the absence of sequence-based data. It
is important for clinical microbiology laboratories to have aware-
ness of brown-pigmented mycobacteria (such that a mycobacte-
rium would not be ruled out based on this phenotype) and also to
consider mycobacterial cultures in unusual cases of endocarditis.
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